Arcus Biosciences, Inc. (RCUS)
21.64
-0.79
(-3.52%)
USD |
NYSE |
Mar 20, 16:00
21.65
+0.01
(+0.05%)
Pre-Market: 20:00
Arcus Biosciences Research and Development Expense (Quarterly) : 121.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.565B |
| Eli Lilly & Co. | 3.802B |
| Merck & Co., Inc. | 2.499B |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |